Tokyo, July 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058459) titled 'Comparison of the Effectiveness of CDK4/6 Inhibitors as First-Line or Later-Line Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer' on July 15.
Study Type:
Observational
Primary Sponsor:
Institute - Fukui University
Condition:
Condition - Breast Cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - By evaluating the effectiveness of one or two reimbursed CDK4/6 inhibitors, as well as treatments administered before and after their use, this study aims to provide evidence that could greatly contribute to treatment decision-...